Enanta Pharmaceuticals Stock Price on December 11, 2024
| ENTA Stock | USD 6.29 0.71 10.14% |
Below is the normalized historical share price chart for Enanta Pharmaceuticals extending back to March 21, 2013. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Enanta Pharmaceuticals stands at 6.29, as last reported on the 12th of December 2024, with the highest price reaching 6.95 and the lowest price hitting 6.25 during the day.
If you're considering investing in Enanta Stock, it is important to understand the factors that can impact its price. Enanta Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.24, which denotes the company had a -0.24% return per unit of standard deviation over the last 3 months. Enanta Pharmaceuticals exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Enanta Pharmaceuticals' Mean Deviation of 2.59, coefficient of variation of (504.59), and Standard Deviation of 3.8 to check the risk estimate we provide.
The current year's Stock Based Compensation To Revenue is expected to grow to 0.42, whereas Common Stock Shares Outstanding is forecasted to decline to about 18.4 M. . At present, Enanta Pharmaceuticals' Price To Sales Ratio is projected to slightly decrease based on the last few years of reporting. The current year's Price Book Value Ratio is expected to grow to 1.88, whereas Price Earnings Ratio is projected to grow to (1.79). Enanta Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 21st of March 2013 | 200 Day MA 12.7896 | 50 Day MA 10.5559 | Beta 0.568 |
Enanta |
Sharpe Ratio = -0.2432
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ENTA |
Estimated Market Risk
| 4.01 actual daily | 35 65% of assets are more volatile |
Expected Return
| -0.98 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.24 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Enanta Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Enanta Pharmaceuticals by adding Enanta Pharmaceuticals to a well-diversified portfolio.
Price Book 1.1517 | Enterprise Value Ebitda (0.29) | Price Sales 2.0617 | Shares Float 15.4 M | Wall Street Target Price 16.875 |
Related Headline
Monte Rosa Headline on 11th of December 2024
Monte Rosa Therapeutics Announces Closing of Global License ... by gurufocus.com
BOSTON, Dec. 11, 2024 -- Monte Rosa Therapeutics, Inc. , a clinical-stage biotechnology company developing novel molecular glue degrad
Enanta Pharmaceuticals Valuation on December 11, 2024
It is possible to determine the worth of Enanta Pharmaceuticals on a given historical date. On December 11, 2024 Enanta was worth 8.55 at the beginning of the trading date compared to the closed value of 7.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Enanta Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Enanta Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Enanta Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Enanta Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 8.94 | 9.59 | 8.57 | 8.64 | 429,752 | |
12/11/2024 | 8.55 | 8.74 | 6.90 | 7.00 | 1,068,231 |
| 6.85 | 6.95 | 6.25 | 6.29 | 780,688 |
| Backtest Enanta Pharmaceuticals | | | Enanta Pharmaceuticals History | | | Enanta Pharmaceuticals Valuation | Previous | Next |
Enanta Pharmaceuticals Trading Date Momentum on December 11, 2024
| On December 12 2024 Enanta Pharmaceuticals was traded for 6.29 at the closing time. The top price for the day was 6.95 and the lowest listed price was 6.25 . The trading volume for the day was 780.7 K. The trading history from December 12, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 10.14% . The overall trading delta against the current closing price is 2.14% . |
Enanta Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Enanta Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Enanta Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Enanta financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Enanta Pharmaceuticals Stock history
Enanta Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Enanta is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Enanta Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Enanta Pharmaceuticals stock prices may prove useful in developing a viable investing in Enanta Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 21.2 M | 18.4 M | |
| Net Loss | -109.6 M | -104.1 M |
Enanta Pharmaceuticals Quarterly Net Working Capital |
|
Enanta Pharmaceuticals Stock Technical Analysis
Enanta Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Enanta Pharmaceuticals Period Price Range
Low | December 12, 2024
| High |
0.00 | 0.00 |
Enanta Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Enanta Pharmaceuticals December 12, 2024 Market Strength
Market strength indicators help investors to evaluate how Enanta Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Enanta Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Enanta Pharmaceuticals stock market strength indicators, traders can identify Enanta Pharmaceuticals entry and exit signals to maximize returns
Enanta Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Enanta Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Enanta Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Enanta to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.14) | |||
| Jensen Alpha | (0.83) | |||
| Total Risk Alpha | (1.37) | |||
| Treynor Ratio | (1.41) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Enanta Stock analysis
When running Enanta Pharmaceuticals' price analysis, check to measure Enanta Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enanta Pharmaceuticals is operating at the current time. Most of Enanta Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Enanta Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enanta Pharmaceuticals' price. Additionally, you may evaluate how the addition of Enanta Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |